UK’s Enterprise gets £5.7m backing for ‘universal’ cystic fibrosis drugEnterprise Therapeutics has been awarded a block of funding from the Cystic Fibrosis Foundation to take a new, Share XUK’s Enterprise gets £5.7m backing for ‘universal’ cystic fibrosis drughttps://pharmaphorum.com/news/uks-enterprise-gets-5-7m-backing-for-universal-cystic-fibrosis-drug/
Roche sets analysts purring with strong Q3 resultsRoche has beaten market expectations in third quarter results, with new drugs gaining traction and its older medicines Share XRoche sets analysts purring with strong Q3 resultshttps://pharmaphorum.com/news/roche-sets-analysts-purring-with-strong-q3-results/
Expect more M&A as Gilead names Dickinson as finance chief, say analystsGilead Sciences has named head of corporate development and strategy Andrew Dickinson as its new chief financial officer Share XExpect more M&A as Gilead names Dickinson as finance chief, say analystshttps://pharmaphorum.com/news/expect-more-ma-as-gilead-names-dickinson-as-finance-chief-say-analysts/
J&J brushes off concerns over talc, opioid and Risperdal litigationJohnson & Johnson has brushed off investors’ concerns over the many lawsuits it is facing, saying its legal Share XJ&J brushes off concerns over talc, opioid and Risperdal litigationhttps://pharmaphorum.com/news/jj-brushes-off-concerns-over-litigation/
W2O acquires med comms agency Arcus MedicaHealthcare marketing communications agency W2O has acquired Philadelphia’s Arcus Medica to boost its scientific and med comms offering. Share XW2O acquires med comms agency Arcus Medicahttps://pharmaphorum.com/news/w2o-med-comms-agency-arcus-medica/
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200mTakeda is to sell off a portfolio of over-the-counter and prescription drugs in the Near East, Middle East, Share XDebt-laden Takeda to sell OTC drugs in Middle East and Africa for $200mhttps://pharmaphorum.com/news/takeda-to-sell-otc-drugs-in-middle-east-and-africa-for-200m/
Pfizer’s Xeljanz follow-up abrocitinib gathers momentumPfizer has reported new data with abrocitinib, a follow-up to its JAK inhibitor Xeljanz, which is facing increased Share XPfizer’s Xeljanz follow-up abrocitinib gathers momentumhttps://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/
Sanofi opens digital biologics manufacturing siteSanofi has opened a manufacturing facility in the US, one of the world’s first facilities using digital continuous Share XSanofi opens digital biologics manufacturing sitehttps://pharmaphorum.com/news/sanofi-opens-digital-biologics-manufacturing-site/
Reata rockets on data for Nrf2 drug reacquired from AbbVieReata Pharma has reported positive clinical results with one of its Nrf2 activators for mitochondrial diseases, just days Share XReata rockets on data for Nrf2 drug reacquired from AbbViehttps://pharmaphorum.com/news/reata-rockets-on-data-for-nrf2-drug-reacquired-from-abbvie/
FDA approves Bayer/Janssen’s Xarelto in new blood clot prevention useBayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA Share XFDA approves Bayer/Janssen’s Xarelto in new blood clot prevention usehttps://pharmaphorum.com/news/fda-approves-bayer-janssens-xarelto-in-new-blood-clot-prevention-use/
Guido Körfer and Marc Henschel join McCann Health GermanyPictured from left: Guido Körfer, Effie Baoutis and Marc Henschel McCann Health Germany has made two key appointments Share XGuido Körfer and Marc Henschel join McCann Health Germanyhttps://pharmaphorum.com/news/korfer-henschel-mccann-health-germany/
Roche backs Rituxan with further data in rare skin disease PVRoche’s Rituxan (rituximab) has been on the market for years as a blood cancer drug, and is finally Share XRoche backs Rituxan with further data in rare skin disease PVhttps://pharmaphorum.com/news/roche-backs-rituxan-with-further-data-in-rare-skin-disease-pv/
NHS-backed mental health site launches in EnglandPublic Health England and the NHS have launched an online service helping people to take simple steps to Share XNHS-backed mental health site launches in Englandhttps://pharmaphorum.com/news/nhs-backed-mental-health-site-launches-in-england/
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging techLA-based biotech ImaginAb has signed a multi-party agreement with pharma giants AstraZeneca, Pfizer, and Takeda, for technology that Share XImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging techhttps://pharmaphorum.com/news/imaginab-joins-with-az-pfizer-and-takeda-to-develop-tumour-imaging-tech/
New price gets Clovis’ PARP inhibitor on the CDFNICE has reversed its decision on Clovis Oncology’s PARP inhibitor Rubraca (rucaparib) and will allow the drug to Share XNew price gets Clovis’ PARP inhibitor on the CDFhttps://pharmaphorum.com/news/new-price-gets-clovis-parp-inhibitor-on-the-cdf/
FDA approves Lilly’s new migraine attack drug, rival from Allergan could followThe FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms Share XFDA approves Lilly’s new migraine attack drug, rival from Allergan could followhttps://pharmaphorum.com/news/fda-approves-lillys-new-migraine-attack-drug-rival-from-allergan-could-follow/
UPS gets clearance to expand medical drone delivery service across USA subsidiary of UPS has gained regulatory clearance allowing it to expand a medical drone delivery service to Share XUPS gets clearance to expand medical drone delivery service across UShttps://pharmaphorum.com/news/ups-gets-clearance-to-expand-medical-drone-delivery-service-in-us/
BioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetsTwo of the largest ever biotech IPOs have gone ahead this week, although both BioNTech and Vir Biotechnology Share XBioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetshttps://pharmaphorum.com/news/biontech-and-virs-mega-ipos-go-ahead-but-struggle-to-meet-price-targets/
SMi’s 3D Cell Culture conference 2020 – Speakers announced Share XSMi’s 3D Cell Culture conference 2020 – Speakers announcedhttps://pharmaphorum.com/partner-content/smis-3d-cell-culture-conference-2020-speakers-announced/
Winners announced for 6th Annual World ADC Awards Share XWinners announced for 6th Annual World ADC Awardshttps://pharmaphorum.com/partner-content/winners-announced-for-6th-annual-world-adc-awards/
Medical Tourism Market to register 6.5% CAGR up to 2025 Share XMedical Tourism Market to register 6.5% CAGR up to 2025https://pharmaphorum.com/partner-content/medical-tourism-market-to-register-6-5-cagr-up-to-2025/
Orthopedic Devices Market Profiled NuVasive, Stryker, Medtronic, Globus Medical by 2025 Share XOrthopedic Devices Market Profiled NuVasive, Stryker, Medtronic, Globus Medical by 2025https://pharmaphorum.com/partner-content/orthopedic-devices-market-profiled-nuvasive-stryker-medtronic-globus-medical-by-2025/
Ashfield Commercial and Patient Solutions appoints President of Global Business Development Share XAshfield Commercial and Patient Solutions appoints President of Global Business Developmenthttps://pharmaphorum.com/partner-content/ashfield-commercial-and-patient-solutions-appoints-president-of-global-business-development/
90TEN makes new appointments to senior management team Share X90TEN makes new appointments to senior management teamhttps://pharmaphorum.com/sales-marketing/90ten-makes-new-appointments-to-senior-management-team/
